SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 102 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $6,164,000 | +54.0% | 550,339 | +51.2% | 0.02% | +30.8% |
| Q2 2017 | $4,003,000 | +100.6% | 363,865 | +78.7% | 0.01% | +85.7% |
| Q1 2017 | $1,996,000 | -7.5% | 203,661 | +2.0% | 0.01% | -12.5% |
| Q4 2016 | $2,157,000 | +0.2% | 199,761 | -4.9% | 0.01% | -11.1% |
| Q3 2016 | $2,152,000 | -6.6% | 209,961 | +19.0% | 0.01% | -25.0% |
| Q2 2016 | $2,305,000 | +12.3% | 176,461 | -5.4% | 0.01% | +9.1% |
| Q1 2016 | $2,052,000 | +12.7% | 186,561 | -5.7% | 0.01% | 0.0% |
| Q4 2015 | $1,820,000 | +35.3% | 197,856 | +3.4% | 0.01% | +37.5% |
| Q3 2015 | $1,345,000 | -30.2% | 191,361 | -2.4% | 0.01% | -46.7% |
| Q2 2015 | $1,926,000 | +7.8% | 196,163 | -2.7% | 0.02% | +7.1% |
| Q1 2015 | $1,786,000 | +26.8% | 201,561 | +25.3% | 0.01% | +27.3% |
| Q4 2014 | $1,409,000 | -3.2% | 160,861 | -23.9% | 0.01% | 0.0% |
| Q3 2014 | $1,456,000 | +91.8% | 211,361 | +46.4% | 0.01% | +83.3% |
| Q2 2014 | $759,000 | +16.1% | 144,361 | +0.6% | 0.01% | 0.0% |
| Q1 2014 | $654,000 | -8.5% | 143,561 | +1.3% | 0.01% | -14.3% |
| Q4 2013 | $715,000 | +8.8% | 141,761 | +9.6% | 0.01% | -12.5% |
| Q3 2013 | $657,000 | +7.5% | 129,361 | +4.9% | 0.01% | -11.1% |
| Q2 2013 | $611,000 | – | 123,261 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|